Replies to post #117526 on Regen BioPharma Inc (RGBP)

[kfox]

I think you’re wrong. Koos is no genius. His work is good but not far advanced or groundbreaking as far as I can tell. And he’s greedy. His OTC history, while it has a few excellent runs includes a list of big failures. His big run from trips to 8 cents was only great because the basis was trips. He went from 20 cents to trips to get there. A lot of losses on the way down never fully made up in magnitude on the way up.

Also opinion and not advice. I think I still own ENTB, a Koos precursor to RGBP.